0001062993-23-001323.txt : 20230124 0001062993-23-001323.hdr.sgml : 20230124 20230124160632 ACCESSION NUMBER: 0001062993-23-001323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230120 FILED AS OF DATE: 20230124 DATE AS OF CHANGE: 20230124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCann Corey CENTRAL INDEX KEY: 0001881049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39969 FILM NUMBER: 23548200 MAIL ADDRESS: STREET 1: C/O PEAR THERAPEUTICS, INC. STREET 2: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001835567 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 854103092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Thimble Point Acquisition Corp. DATE OF NAME CHANGE: 20201208 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-01-20 0001835567 Pear Therapeutics, Inc. PEAR 0001881049 McCann Corey C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109 1 1 0 0 President and CEO Class A Common Stock 2023-01-20 4 S 0 34731 1.13 D 8210834 D Class A Common Stock 1685913 I by The Corey M. McCann Irrevocable Trust of 2021 Class A Common Stock 986517 I by The McCann Family Trust The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein. Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll. Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company. /s/ Stacie S. Aarestad, Attorney-in-Fact 2023-01-24